| Treatment | Talc slurry | Talc poudrage | Bleomycin | Tetracycline | C. parvum | Mitoxantrone |
| Talc poudrage | 1.02 (0.35, 3.00); Tau2 = 0.43; I2 = 69%; n = 2 |
NA | ‐ | ‐ | ‐ | ‐ |
| Bleomycin | 0.89 (0.29, 2.75); Tau2 = 0; I2 = 0%; n = 2 |
0.82 (0.20, 3.43); n = 1 | NA | ‐ | ‐ | ‐ |
| Tetracycline | NA | 0.19 (0.03, 0.10); n = 1 | 1.60 (0.69, 3.69); Tau2 = 0.0; I2 = 0%; n = 2 |
NA | ‐ | ‐ |
|
C. parvum |
NA | NA | 1.66 (0.51, 5.38); n = 1 | 0.33 (0.03, 3.55); n=1 | NA | ‐ |
| Interferon | NA | NA | 2.16 (1.15, 4.07); n = 1 | NA | NA | NA |
| Iodine | NA | 0.38 (0.08, 1.73); n = 1 | NA | NA | NA | NA |
| Indwelling pleural catheter | 1.30 (0.48, 2.23) Tau2 = 0.08; I2 = 25%; n = 2 | NA | NA | NA | NA | NA |
| Mustine | NA | 2.35 (0.51, 10.86); n = 1 | NA | NA | 2.40 (0.38, 15.32); n = 1 | NA |
| Mitoxantrone | NA | NA | 0.47 (0.21, 1.05); n = 1 | NA | NA | NA |
| Mepacrine | 0.53 (0.28, 1.61); n = 1 | NA | NA | NA | NA | 1.64 (0.23, 11.70); n = 1 |
| Doxycycline | NA | NA | 0.69 (0.26, 1.87); n = 1 | NA | NA | NA |
| n = the number of studies included in the pair‐wise comparison. * indicates that the comparison included a three‐arm study. NA = no direct pair‐wise comparison available. Results that are statistically significant at the conventional level of P < 0.05 are shaded in grey. ‐ indicates the odds ratio is already expressed elsewhere in the table comparing the interventions the other way around | ||||||
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.